Loading...
XNASXFOR
Market cap108mUSD
Jan 08, Last price  
0.64USD
1D
-9.36%
1Q
21.45%
IPO
-95.81%
Name

X4 Pharmaceuticals Inc

Chart & Performance

D1W1MN
XNAS:XFOR chart
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
229.33%
Rev. gr., 5y
%
Revenues
0k
0003,500,00003,000,000000
Net income
-101m
L+7.78%
-13,218,000-22,975,000-33,877,000-43,021,000-56,604,000-62,131,000-88,696,000-93,867,000-101,167,000
CFO
-97m
L+25.17%
-10,816,000-21,639,000-27,871,000-40,903,000-48,055,000-58,818,000-70,905,000-77,102,000-96,512,000
Earnings
Mar 19, 2025

Profile

Actelis Networks, Inc., a networking solutions company, designs, develops, manufactures, and markets networking solutions for Internet of Things and telecommunication companies in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. It offers ethernet access devices, aggregation switches, broadband amplifiers, and repeaters, as well as element management systems software. The company also provides consulting, troubleshooting, remote support, training, product repairing, and software update services. It serves the intelligent traffic systems, education and industrial campus, airport, smart city, rail, military, energy, oil and gas, and water sectors. The company was founded in 1998 and is based in Fremont, California.
URL
https://www.x4pharma.com/
IPO date
Nov 16, 2017
Employees
40
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
74,013
63,052
Unusual Expense (Income)
NOPBT
(74,013)
(63,052)
NOPBT Margin
Operating Taxes
78
28
Tax Rate
NOPAT
(74,091)
(63,080)
Net income
(101,167)
7.78%
(93,867)
5.83%
Dividends
Dividend yield
Proceeds from repurchase of equity
59,999
122,631
BB yield
-40.24%
-194.40%
Debt
Debt current
2,198
2,513
Long-term debt
60,893
40,708
Deferred revenue
Other long-term liabilities
16,115
23,304
Net debt
(51,125)
(79,522)
Cash flow
Cash from operating activities
(96,512)
(77,102)
CAPEX
(60)
(103)
Cash from investing activities
(14,883)
(103)
Cash from financing activities
88,516
117,230
FCF
(72,153)
(61,189)
Balance
Cash
114,216
121,718
Long term investments
1,025
Excess cash
114,216
122,743
Stockholders' equity
(477,857)
(376,735)
Invested Capital
604,451
512,510
ROIC
ROCE
EV
Common stock shares outstanding
177,812
63,526
Price
0.84
-15.56%
0.99
-56.64%
Market cap
149,096
136.35%
63,081
6.98%
EV
97,971
(16,441)
EBITDA
(73,594)
(62,539)
EV/EBITDA
0.26
Interest
5,777
3,993
Interest/NOPBT